Translational Development Acquisition Corp. (TDAC) Form 8-K — Jul 27, 2026
Translational Development Acquisition Corp. entered into a subscription agreement with Naetas Holding Limited to sell 5,000,000 Class A ordinary shares at $10.00 per share, resulting in $50,000,000 in gross proceeds. The subscriber will also receive 5,000,000 warrants at no additional cost, exercisable at $11.50 per share with a redemption trigger at $18.00. The closing of this private investment is contingent upon the consummation of the business combination with Prologium Holding Inc., scheduled for one business day prior to the merger.
Key figures
- Gross Proceeds
- $50,000,000
- Offering Price
- $10.00
- Shares Offered
- 5000000
- Warrants issued
- 5000000
- Redemption price
- $0.01
- Warrant exercise price
- $11.50
- Redemption trigger threshold
- $18.00
Price after filing
Close on the filing date to close N calendar days later (from $10.74). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.